Plain-English translation of NCT06476808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-in-human trial testing a new experimental medication called for people with advanced cancers that have spread or cannot be surgically removed. The study will carefully increase the dose of this medication over time to find the right amount that works best while being safe. Researchers want to understand how this treatment affects different types of ovarian, uterine, and lung cancers.
This medication is brand new and has never been tested in people before, so researchers need to learn if it is safe and whether it can help patients with these advanced cancers. By testing at gradually higher doses, doctors can find the safest and most effective level.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will start by having a small tissue sample taken from your tumor. Then you will begin receiving the medication, starting at a low dose that may be increased over time depending on how your body responds and how safe it is. You will have regular visits with the research team for check-ups, blood tests, and scans to monitor how the treatment is working and watch for any side effects.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States